fei yee lee, farida islahudin, abdul halim abdul gafor, hin-seng wong, sunita bavanandan, shamin mohd saffian, adyani md redzuan, mohd makmor-bakry.  (2022).  adverse drug reactions of antihypertensives and cyp3a5*3 polymorphism among chronic kidney disease patients.  - frontiers in pharmacology.  1-8. 

hock peng koh, adyani md redzuan, shamin mohd saffian, jivanraj nagarajah, noel thomas ross, hasnita hassan.  (2022).  impact of covid-19 pandemic on stemi thrombolysis and emergency department's performance in a non-pci capable tertiary hospital.  - american journal of emergency medicine.  9-14. 

hock peng koh, adyani md redzuan, shamin mohd saffian, jivanraj r. nagarajah, noel thomas ross, hasnita hassan.  (2022).  clinical profile and predictors of 30-day all-cause mortality of stelevation myocardial infarction (stemi) patients receiving fibrinolytic therapy in an asian population.  - heart & lung.  68-76. 

fei yee lee, farida islahudin, aina yazrin ali nasiruddin, abdul halim abdul gafor, hin-seng wong, sunita bavanandan, shamin mohd saffian, adyani md redzuan, nurul ain mohd tahir, mohd makmor-bakry.  (2021).  effects of cyp3a5 polymorphism on rapid progression of chronic kidney disease: a prospective, multicentre study.  - journal of personalized medicine.  1-14. 

salmi abdul razak, mohd makmor bakry, mohd shahrir mohamed said, chai-eng tan, adyani md redzuan.  (2020).  development and validation of adherence score for subcutaneous biologic disease-modifying antirheumatic drugs.  - frontiers in pharmacology.  1-9. 

hock peng koh, adyani md redzuan, shamin mohd saffian, jivanraj r. nagarajah, noel thomas ross, hasnita hassan.  (2022).  the outcomes of reperfusion therapy with streptokinase versus tenecteplase in st-elevation myocardial infarction (stemi): a propensity-matched retrospective analysis in an asian population.  - international journal of clinical pharmacy.  641-650. 

farizan abdul-ghaffar, adyani md redzuan, mohd makmor-bakry, mohamad arif muhamad nor.  (2022).  drug-related problems in pulmonary hypertension with valvular heart disease.  - therapeutics and clinical risk management.  1069-1079. 

endang kumolosasi, mandy cheong li ching, nuraina athira ahmad salwanizam, nur shamizah ainna muhammad esham, qistina alyani ayob, ramavisithira ramasamy, harishankari govindan, adyani md redzuan, malina jasamai.  (2022).  drug-herb interactions: selected antihypertensive drugs with moringa oleifera leaves extract.  - sains malaysiana.  1143-1154. 

shantini radhakrishnan, salmi abdul razak, mohd shahrir mohamed said, noraida mohamed shah, adyani md redzuan.  (2022).  cardiovascular risks and primary interventions among treated rheumatoid arthritis patients: experience from a tertiary care centre in kuala lumpur, malaysia.  - tropical journal of pharmaceutical research.  863-870. 

amutha selvaraj, adyani md redzuan, ernieda hatah.  (2020).  community pharmacists' perceptions, attitudes and barriers towards pharmacist-led minor ailment services in malaysia.  - international journal of clinical pharmacy.  777-785. 

fei yee lee, farida islahudin, abdul halim abdul gafor, hin-seng wong, sunita bavanandan, shamin mohd saffian, adyani md redzuan, mohd makmor-bakry.  (2022).  adverse drug reactions of antihypertensives and cyp3a5*3 polymorphism among chronic kidney disease patients.  - frontiers in pharmacology.  1-8. 

farizan abdul-ghaffar, adyani md redzuan, mohd makmor-bakry, mohamad arif muhamad nor.  (2022).  drug-related problems in pulmonary hypertension with valvular heart disease.  - therapeutics and clinical risk management.  1069-1079. 

zainol akbar zainal, shairyzah ahmad hisham, adyani md redzuan, saliha roslan.  (2022).  pharmacy graduates experiences and perception on psychiatry pharmacy experiential learning or clerkship in selangor, malaysia.  - neuroquantology.  3780-3786. 

hock peng koh, adyani md redzuan, shamin mohd saffian, jivanraj r. nagarajah, noel thomas ross, hasnita hassan.  (2022).  the outcomes of reperfusion therapy with streptokinase versus tenecteplase in st-elevation myocardial infarction (stemi): a propensity-matched retrospective analysis in an asian population.  - international journal of clinical pharmacy.  641-650. 

hock peng koh, adyani md redzuan, shamin mohd saffian, jivanraj nagarajah, noel thomas ross, hasnita hassan.  (2022).  impact of covid-19 pandemic on stemi thrombolysis and emergency department's performance in a non-pci capable tertiary hospital.  - american journal of emergency medicine.  9-14. 

adliah mhd ali, adyani redzuan.  (2020).  penyelidikan kepatuhan terhadap ubat : impak, punca dan penyelesaian.  - .  100. 

adliah mhd ali, adyani redzuan.  (2020).  penyelidikan kepatuhan terhadap ubat : impak, punca dan penyelesaian.  - .  100. 

farida hanim binti islahudin;mohd bin makmor bakry;adyani binti md redzuan;shamin bin mohd saffian.  (2022).  elucidating mechanism of cyp450 gene polymorphisms on drug metabolism in renal failure.  - .  . 

sasha muhammed elamin, noraida mohamed shah, adyani md redzuan, siti azdiah abdul aziz.  (2022).  effectiveness of educational interventions on glycemia control in children with t1dm - a scoping review.  - international conference on pharmaceutical sciences icops@iium2022.  63. 

malina binti jasamai;adyani binti md redzuan;endang kumolosasi.  (2022).  possible drug-herb interactions between merunggai (moringa oleifera) standardized extracts with antihypertensive agents .  - .  . 

adyani md redzuan, hock peng koh, shamin mohd saffian, jivanraj r. nagarajah, noel thomas ross, hasnita hassan.  (2021).  the outcomes of streptokinase versus tenecteplase in st-elevation myocardial infarction (stemi): a propensity-matched retrospective analysis in a multiracial asian country.  - 3rd international conference of pharmacy and health sciences 2021 (icphs 2021).  155. 

farhana fakhira ismail, adyani md. redzuan, chong wei wen.  (2021).  effectiveness of patient-centered education in dyslipidemia management: a systematic review.  - 3rd international conference of pharmacy and health sciences 2021 (icphs 2021).  162.